These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 36041646)

  • 21. Brequinar inhibits enterovirus replication by targeting biosynthesis pathway of pyrimidines.
    Fu H; Zhang Z; Dai Y; Liu S; Fu E
    Am J Transl Res; 2020; 12(12):8247-8255. PubMed ID: 33437396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern.
    Setz C; Große M; Auth J; Fröba M; Rauch P; Bausch A; Wright M; Schubert U
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
    Patil AM; Göthert JR; Khairnar V
    Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Broad-Spectrum Antiviral Inhibitors Targeting Host Factors Essential for Replication of Pathogenic RNA Viruses.
    Tampere M; Pettke A; Salata C; Wallner O; Koolmeister T; Cazares-Körner A; Visnes T; Hesselman MC; Kunold E; Wiita E; Kalderén C; Lightowler M; Jemth AS; Lehtiö J; Rosenquist Å; Warpman-Berglund U; Helleday T; Mirazimi A; Jafari R; Puumalainen MR
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33322045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2.
    Biering SB; Van Dis E; Wehri E; Yamashiro LH; Nguyenla X; Dugast-Darzacq C; Graham TGW; Stroumza JR; Golovkine GR; Roberts AW; Fines DM; Spradlin JN; Ward CC; Bajaj T; Dovala D; Schulze-Gamen U; Bajaj R; Fox DM; Ott M; Murthy N; Nomura DK; Schaletzky J; Stanley SA
    ACS Infect Dis; 2021 Aug; 7(8):2337-2351. PubMed ID: 34129317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pharmacokinetic drug-drug interaction study between rosuvastatin and emvododstat, a potent anti-SARS-CoV-2 (COVID-19) DHODH (dihydroorotate dehydrogenase) inhibitor.
    Morton TL; Laskin OL; Kaushik D; Lee L; Ma J; Kristensen A; O'Keefe K; Golden L; Klein M; Kong R
    Pharmacol Res Perspect; 2023 Apr; 11(2):e01076. PubMed ID: 36938928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitors of Anti-apoptotic Bcl-2 Family Proteins Exhibit Potent and Broad-Spectrum Anti-mammarenavirus Activity via Cell Cycle Arrest at G0/G1 Phase.
    Kim YJ; Witwit H; Cubitt B; de la Torre JC
    J Virol; 2021 Nov; 95(24):e0139921. PubMed ID: 34586865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo.
    Müller C; Obermann W; Karl N; Wendel HG; Taroncher-Oldenburg G; Pleschka S; Hartmann RK; Grünweller A; Ziebuhr J
    Antiviral Res; 2021 Feb; 186():105012. PubMed ID: 33422611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of pyrimidine biosynthesis by targeting DHODH enzyme robustly inhibits rotavirus replication.
    Chen S; Ding S; Yin Y; Xu L; Li P; Peppelenbosch MP; Pan Q; Wang W
    Antiviral Res; 2019 Jul; 167():35-44. PubMed ID: 30974126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.
    de Wilde AH; Wannee KF; Scholte FE; Goeman JJ; Ten Dijke P; Snijder EJ; Kikkert M; van Hemert MJ
    J Virol; 2015 Aug; 89(16):8318-33. PubMed ID: 26041291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19.
    van de Leemput J; Han Z
    Mol Cell Biol; 2021 Aug; 41(9):e0018521. PubMed ID: 34124934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease.
    Kreutzberger AJB; Sanyal A; Ojha R; Pyle JD; Vapalahti O; Balistreri G; Kirchhausen T
    J Virol; 2021 Oct; 95(21):e0097521. PubMed ID: 34406858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nodosome Inhibition as a Novel Broad-Spectrum Antiviral Strategy against Arboviruses, Enteroviruses, and SARS-CoV-2.
    Limonta D; Dyna-Dagman L; Branton W; Mancinelli V; Makio T; Wozniak RW; Power C; Hobman TC
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0049121. PubMed ID: 34001511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and Tracking of Antiviral Drug Combinations.
    Ianevski A; Yao R; Biza S; Zusinaite E; Mannik A; Kivi G; Planken A; Kurg K; Tombak EM; Ustav M; Shtaida N; Kulesskiy E; Jo E; Yang J; Lysvand H; Løseth K; Oksenych V; Aas PA; Tenson T; Vitkauskienė A; Windisch MP; Fenstad MH; Nordbø SA; Ustav M; Bjørås M; Kainov DE
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33080984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2.
    Subhadra B; Agrawal R; Pal VK; Chenine AL; Mattathil JG; Singh A
    Viruses; 2023 May; 15(6):. PubMed ID: 37376598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Broad-spectrum inhibition of common respiratory RNA viruses by a pyrimidine synthesis inhibitor with involvement of the host antiviral response.
    Cheung NN; Lai KK; Dai J; Kok KH; Chen H; Chan KH; Yuen KY; Kao RYT
    J Gen Virol; 2017 May; 98(5):946-954. PubMed ID: 28555543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
    Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L
    Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molnupiravir and Its Antiviral Activity Against COVID-19.
    Tian L; Pang Z; Li M; Lou F; An X; Zhu S; Song L; Tong Y; Fan H; Fan J
    Front Immunol; 2022; 13():855496. PubMed ID: 35444647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential inhibitors of SARS-CoV-2: recent advances.
    Jamalipour Soufi G; Iravani S
    J Drug Target; 2021 Apr; 29(4):349-364. PubMed ID: 33210953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors.
    Zhao J; Zhang G; Zhang Y; Yi D; Li Q; Ma L; Guo S; Li X; Guo F; Lin R; Luu G; Liu Z; Wang Y; Cen S
    Antiviral Res; 2021 Dec; 196():105209. PubMed ID: 34801588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.